Le Lézard
Classified in: Health
Subjects: NPT, VET

McAlister's Deli Launches Cookies for a Cause Campaign in Support of Wounded Warrior Project


DALLAS, Nov. 1, 2017 /PRNewswire-USNewswire/ -- To raise support for Wounded Warrior Project® (WWP), The Saxton Group, McAlister's Deli's largest franchisee, will kick off the next iteration of its Cookies for a Cause campaign. Throughout November, McAlister's Deli will sell cookies with camouflage and gold star sprinkles, with 50 cents of each cookie sold benefitting the warriors WWP serves.

McAlister's Deli's is launching the next phase of its Cookies for a Cause campaign, benefiting Wounded Warrior Project.

"While we're known for our McAlister's Famous Sweet Teatm, our cookies are just as sweet, and this cause makes them even sweeter," said The Saxton Group, LLC co-CEO Adam Saxton. "We have locations next to some of the country's biggest military bases and have always supported our nation's bravest. Additionally, we're proud to have a number of veterans and reservists working in our restaurants. This campaign is our way of honoring the heroes who form an important part of our customer and employee base."

Limited edition WWP cookies will be sold from Nov. 1 through Nov. 30, 2017. For a list of locations, visit http://www.thesaxtongroup.com/locations. McAlister's Deli is recognized in the top 25 of the 2017 "Entrepreneur Franchise 500." FastCasual.com has recognized the brand on its "Top 100 Movers and Shakers" list of 2015 and 2016.

"Wounded Warrior Project has served over 100,000 warriors, caregivers, and family members because of the generosity of our supporters," said WWP CEO Lt. Gen. (Ret.) Mike Linnington. "We're extremely grateful that McAlister's is stepping forward to join our mission to honor and empower Wounded Warriors. Their Cookies for a Cause campaign will give us the fuel needed to continue connecting wounded veterans with services that empower them to live their lives on their terms, at no cost."

To learn more about how donors fuel WWP's programs and services that connect, serve, and empower wounded warriors, visit http://newsroom.woundedwarriorproject.org.

About Wounded Warrior Project
Wounded Warrior Project® (WWP) connects, serves, and empowers wounded warriors. Read more at http://newsroom.woundedwarriorproject.org/about-us.

 

SOURCE Wounded Warrior Project


These press releases may also interest you

at 00:05
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
Few small SUVs excel in new IIHS front crash prevention test
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential expands globally to Oceania, Asia and the Gulf
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

More news about Health...


News published on and distributed by: